NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
Back to search
Official data from USPTO
ANAIXOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/10/2024
Trademark type
Word
Nice classes
5
Filing date
07/27/2022
Registration date
09/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
09/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Baoshan, Shanghai, CN
Examiner
KING, LINDA M
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.
Representatives
Robert J. Kenney Willcox & Savage, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; hematogen for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/06/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/06/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2023
ALIE
ASSIGNED TO LIE
10/16/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/18/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/12/2023
GNSL
LETTER OF SUSPENSION E-MAILED
05/12/2023
CNSL
SUSPENSION LETTER WRITTEN
05/12/2023
DOCK
ASSIGNED TO EXAMINER
05/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2022
NWAP
NEW APPLICATION ENTERED
07/30/2022
Continuous trademark protection
Get notified about every new filing that threatens ANAIXOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.